Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N, Takahashi K, Sato T, Nakamura T, Sawa C, Hasegawa D, Ando H, Aratani S, Yagishita N, Fujii R, Oka H, Nishioka K, Nakajima T, Mori N, Yamano Y.
Araya N, et al. Among authors: oka h.
Antivir Ther. 2011;16(1):89-98. doi: 10.3851/IMP1699.
Antivir Ther. 2011.
PMID: 21311112
Clinical Trial.